Use of Stents and Stent Grafts to Salvage Angioplasty Failures in Patients with Hemodialysis Grafts
|
|
- Nicholas Leonard
- 8 years ago
- Views:
Transcription
1 Use of Stents and Stent Grafts to Salvage Angioplasty Failures in Patients with Hemodialysis Grafts Thomas M. Vesely, Mohammed Zaheer Amin, and Thomas Pilgram St. Louis, Missouri ABSTRACT To determine the efficacy of using stents and stent grafts for treatment of hemodialysis graft-related stenoses which have failed angioplasty. This retrospective study was composed of 51 patients with polytetrafluoroethylene hemodialysis grafts who underwent angioplasty of a graft-related stenosis but subsequently required insertion of a stent or stent graft. The study group included 40 patients with >30% residual stenosis and 11 patients with angioplasty-induced venous ruptures. The patient s medical records and radiology reports were reviewed. Patient demographics, indication for stent placement, and the type of stent were recorded. Stent patency was determined using Kaplan Meier analysis. A total of 70 stents were used; most (57.7%) were deployed across the venous anastomosis. A variety of different types of stents and stent grafts were used including 26 SMART, 18 Viabahn, 13 aspire, and 13 other stents. The technical success rate for insertion of the device was 100%. Following insertion of the device the primary patency of the vascular access was 81%, 70%, and 54% at 1, 3, and 6 months, respectively. The secondary patency of the vascular access was 89%, 82%, and 74% at 3, 6, and 12 months, respectively. The primary patency of the stent or stent graft was 96%, 93%, 87%, and 47% at 1, 3, 6, and 12 months, respectively. Stents and stent grafts are useful for salvaging failed angioplasty procedures and thereby maintaining patency of the hemodialysis graft. By inserting a stent, the resultant patency rates are similar to those following a successful angioplasty procedure. Importantly, the primary patency of the stent was substantially better than the primary patency of the entire vascular access. Angioplasty continues to be the primary percutaneous technique for treatment of venous stenoses associated with arteriovenous fistulas and prosthetic grafts used for hemodialysis (1). It remains the standard treatment to which other percutaneous techniques are compared. A variety of other percutaneous devices have been utilized to treat vascular access-related stenoses. These include the peripheral cutting balloon, cryoplasty, metal stents and stent grafts. Stents and stent grafts appear to be an ideal method to treat neointimal hyperplastic stenoses. These endovascular devices can oppose elastic recoil and optimize endoluminal dimensions thereby improving blood flow through the fistula or graft. However, the use of stents remains controversial. Early studies reported that the routine use of metallic stents failed to provide any additional benefit when compared with angioplasty alone (2,3). More recent publications have reported improved long-term patency rates when stents are used in selected situations (4 6). The usual mode of stent failure is ingrowth of neointimal Address correspondence to: Thomas Vesely, MD, 24 The Boulevard, Suite 420, St. Louis, MO 63117, or tmvesely@aol.com. Seminars in Dialysis Vol 21, No 1 (January February) 2008 pp DOI: /j X x hyperplasic tissue through the mesh of a metallic stent. The use of a covered stent or stent graft would seem to be a logical choice to prevent this problem. But once again, published studies have reported differing results and opinions regarding the value of stent grafts when compared with conventional angioplasty (7,8). The use of stents and stent grafts to treat vascular access-related stenoses continues to be a controversial subject. This retrospective review was performed to evaluate our outcomes when using stents and stent grafts for treatment of venous stenoses which failed to improve with angioplasty and for the repair of angioplastyinduced venous ruptures. Materials and Methods Patients A computer search of the interventional radiology database at our institution was performed to identify all patients with polytetrafluoroethylene (PTFE) hemodialysis grafts who received a stent or stent graft during the 4-year time period from April 2000 to April We did not include patients who had stents placed in the central veins or for treatment of a pseudoaneurysm. Fiftyone patients were included in this study. There were 34 female patients and the median age of all patients was 100
2 STENTS AND STENT GRAFTS IN HEMODIALYSIS years. The indication for the patient s referral to interventional radiology included (i) decreased intragraft blood flow, (ii) elevated venous pressures, (iii) upper extremity swelling, or (iv) graft thrombosis. Thirty-two patients presented with patent, dysfunctional grafts and 19 patients presented with thrombosed grafts. Fortythree patients had loop configuration hemodialysis grafts and seven patients had straight grafts. Thirtythree grafts were located in the left upper extremity, 16 in the right upper extremity, and two in the right thigh. The angiographic images, procedural reports, and medical records of these 51 patients were retrospectively reviewed to document all vascular access-related events. Graft-related procedures that were performed following placementofthestentorstentgraftwerereviewedto determine the patency of the device, the location of venous stenoses, and the cause of vascular access failure. This information was used to determine whether subsequent graft failure resulted from restenosis within the stent or stent graft, or from the development of a new stenosis within the vascular access circuit Procedures An 18 g needle was used to enter the apex of the loopconfiguration PTFE graft. A 5 French angiographic catheter was advanced into the arterial limb of the graft andpositionedwiththedistaltipinthenativeartery adjacent to the arterial anastomosis. A thorough diagnostic fistulogram was performed to evaluate the hemodialysis graft and native outflow veins. Nineteen patients presented with a thrombosed hemodialysis graft. In these patients a thrombectomy procedure was performed after evaluation of the native veins and prior to angioplasty of venous stenoses. A 7 French or 8 French vascular introducer sheath (DialEase; Mallinckrodt Medical, St. Louis, MO) was inserted into the apex of the graft. Heparin (3000 U) was administered to patients undergoing a thrombectomy procedure but was not given to patients with patent grafts. In all 19 patients the thrombectomy procedure was performed using the percutaneous thrombolytic device (Arrow Int., Reading, PA). Angioplasty of venous stenoses was performed after completion of the thrombectomy procedure but before dislodgement of the arterial plug. Stenoses causing greater than 50% luminal reduction were treated with angioplasty. In the majority of patients the degree of stenosis was determined by visual assessment of the lesion on the digital subtraction images. When in doubt, the degree of stenosis was measured using the calibrated software within the digital imaging system. The venous stenosis was crossed with a inch Bentson guidewire (Cook Inc., Bloomington, IN) allowing introduction of an appropriately sized angioplasty balloon. The diameter of the balloon was selected by the operating physician and was typically 10 20% larger than the diameter of a normal venous segment adjacent to the stenosis. The angioplasty balloon was inflated using an insufflator which contained dilute contrast material. Balloon inflation times were typically 60 seconds. Following completion of the angioplasty procedure the balloon catheter was removed and a completion fistulogram was performed by injecting contrast material through the sidearm of the vascular sheath. The postangioplasty fistulogram revealed that 40 patients had greater than 30% residual stenosis and 11 patients had a venous rupture at the site of angioplasty. Because of the failed angioplasty procedure these 51 patients underwent additional treatment with insertion of a stent or stent graft (Fig. 1). The existing introducer sheath was replaced with an 8 French or 9 French sheath. The inch Bentson guidewire which was in position from the angioplasty procedure was utilized for the stent insertion procedure. The length of the venous lesion was measured using the calibrated software within the digital imaging system. The length of the stent or stentgraftwaschosensothatitextendedatleast10mm beyond each end of the lesion. Under fluoroscopic observation the stent delivery catheter was advanced into the graft, and the device was appropriately positioned and deployed across the stenotic segment. After deployment, an appropriate diameter angioplasty balloon was used to fully expand the stent or stent graft and to ensure complete apposition of the device against the vessel wall. A final fistulogram wasperformedtoevaluate the final position of the stent or stent graft (Fig. 1). At the completion of the procedure the introducer sheath was removed and a purse-string suture was used to close the access site at the graft apex. Anticoagulation or antibiotics were not administered during, or following, any of these procedures. Statistical Analysis The entire study group of 51 patients was included in the statistical analysis. Primary patency, assisted primary patency, and secondary patency rates were calculated using Kaplan Meier life table analysis. Primary patency of the vascular access circuit was defined as the time period from stent placement to the next graftrelated event. Assisted primary patency of the vascular access circuit was defined as thetimeperiodfromstent placement to graft thrombosis. Secondary patency was defined as the time period from stent placement to abandonment of the graft. Primary patency of the stent or stent graft was defined as the time period from device placement to restenosis or thrombosis of the device. Kaplan Meier life table analysis, log-rank, and Wilcoxon tests were used for analysis and comparison of subgroups. The three subgroups included (i) 18 patients with SMART stents, (ii) 10 patients with Viabahn stent grafts, and (iii) 10 patients with aspire stent grafts. Only those patients with one type of stent were included in the subgroup analysis. The other stent subgroups had less than five patients and were not included. Results The study group consisted of 51 patients with PTFE hemodialysis grafts who had an unsuccessful angioplasty procedure and underwent treatment with a stent or stent graft.
3 102 Vesely et al. (a) (b) (c) Stent graft Fig. 1. (a) A fistulogram reveals a tight stenosis at the venous anastomosis of a prosthetic hemodialysis graft. (b) Following angioplasty there is significant residual stenosis. (c) Following insertion of an aspire stent graft there is substantial improvement in luminal diameter. TABLE 1. Number of stents and stent grafts by type Stent stent graft type n TABLE 2. Patency rates of the vascular access circuit in 51 patients 1 month 3 months 6 months 12 months SMART 26 Viabahn 18 aspire 13 Wallstent 5 Flare 4 Luminexx 2 Genesis 1 Fluency 1 Total 70 A total of 70 devices were inserted; 34 metal stents, and 36 stent grafts. The number and types of stents and stent grafts is listed in Table 1. Thirty-seven patients received one stent, nine patients received two stents, and five patients received three stents. Four patients received two different types of stents or stent grafts. The technical success rate for insertion of the stent or stent graft is 100%. The majority (57.7%) of stents were deployed across the venous anastomosis. There were no complications associated with the stent or stent graft insertion procedures. The primary patency, assisted primary patency, and secondary patency rates of the vascular access circuit are listed in Table 2 and the Kaplan Meier survival data are showninfig.3. The patency of the stent or stent graft was determined separately from the overall patency of the vascular access circuit. The primary patency rate of the stent or stent graft is 96%, 93%, 87%, and 47% at 1, 3, 6, and 12 months, respectively. The primary patency rates of the three most commonly used stents; the SMART stent, the aspire stent graft, and the Viabahn stent graft, are Primary Assisted primary Secondary TABLE 3. Primary patency by stent type. Includes only patients with one type of stent 1 month 3 months 6 months 12 months SMART (n = 18) aspire (n = 10) Viabahn (n = 10) listed in Table 3 and the Kaplan Meier survival data are shown in Fig. 2. When comparing these three devices there was no difference in their primary patency rates (p =0.59). There was also no difference (p = 0.95) in the primary patency of the vascular access circuit when comparing the group of patients who presented with patent, dysfunctional grafts to those patients who presented with thrombosed grafts. Discussion The long-term follow-up of 51 hemodialysis patients who received a stent or stent graft revealed a 6-month primary patency rate of 54%. Our results are similar to those recently reported by Vogel and Parise who achieved a 6-month primary patency of 51% using the
4 STENTS AND STENT GRAFTS IN HEMODIALYSIS 103 (a) (b) Stent graft Intragraft stenosis Fig. 2. (a) A digital radiograph reveals a Viabahn stent graft crossing the elbow. (b) A fistulogram performed 4 months later demonstrates a patent stent graft and the development of a new stenosis within the hemodialysis graft. Survival aspire SMART Viabahn Days Fig. 3. Graph of primary patency rates for three different stents. nitinol SMART stent (9). In a more recent study, Vogel andpariseachievedevenbetterresultsandreporteda six-month primary patency of 67% when using the nitinol SMART stent for treating venous stenoses (10). These results are substantially better than previous studies which utilized stainless steel stents for the treatment of hemodialysis graft-related stenoses. Patel et al. reported a 6-month primary patency of only 27% when using Wallstents to treat venous anastomotic stenoses following percutaneous thrombectomy procedures (11). Hoffer et al. conducted a randomized, prospective clinical trial comparing angioplasty to the stainless steel Wallstent and reported a 6-month primary patency of only 12% for the 17 patients who received the Wallstent (12). As suggested by Clark, nitinol stents may have advantageous characteristics which provide superior long-term patency when compared with stainless steel stents (3). The current study revealed that the primary patency of the stent or stent graft was better than the primary patency of the entire vascular access. Our retrospective review of the diagnostic fistulograms revealed that in some patients the endpoint of primary patency was the development of a significant stenosis at a new location in the vascular access circuit (Fig. 2). The original lesion that was treated with a stent or stent graft often remained patent and required no additional intervention. Our study suggests that the subgroup of patients who received nitinol SMART stents had a superior primary patency rate at 6 months when compared with those patients who received the PTFE-encapsulated Viabahn stent graft. However, these results may be skewed by the small numbers of patients in each subgroup. The 3 and 12 month primary patency rates for those patients who received SMART stents were similar to the patency rates of those patients who received the Viabahn stent graft. Vascular stents can be beneficial for the treatment of angioplasty-induced venous rupture. In the event of a venous rupture the insertion of a stent or stent graft can be performed easily and rapidly. These devices can tamponade the damaged vascular wall and thereby minimize blood loss and perivascular hematoma formation. Previously published studies have demonstrated that metal stents can effectively repair a venous rupture and maintain patency of the graft with three month primary patency rates ranging from 46% to 63% (13,14). In summary, this study has demonstrated that when stents and stent grafts are used to treat angioplasty failures the long-term outcomes are similar to those achieved following a successful angioplasty procedure (1,3,15). Disclosure Dr. Vesely is a consultant for W. L. Gore and Bard Peripheral Vascular. References 1. Gray RJ: Angioplasty and stents for peripheral and central venous lesions. Tech Vasc Interv Radiol 2: , Lorenz JM: Use of stents for maintenance of hemodialysis access. Semin Interv Radiol 21: , Clark TW: Nitinol stents in hemodialysis access. J Vasc Interv Radiol 15: , Maya I, Allon M: Outcomes of thombosed arteriovenous grafts: comparison of stents vs. angioplasty. Kidney Int 69: , Sreenarasimhaiah VP, Margassery SK, Martin KJ, Bander SJ: Salvage of thrombosed dialysis access grafts with venous anastomosis stents. Kidney Int 67: , Pan HB, Liang HL, Lin YH, Chung HM, Wu TW, Chen CY, Fang HC, Chen CK, Lai PH, Yang CF: Metallic stent placement for treating peripheral outflow lesions in native arteriovenous fistula hemodialysis patients after insufficient balloon dilatation. AJR 184: , Vesely TM: Use of the aspire covered stent for treatment of hemodialysis graft-related stenoses. J Vasc Interv Radiol 13:S38, 2002
5 104 Vesely et al. 8. Haskal ZJ, Mietling S, Schuman E, Altman S, Bermann S, McLennan G, Trerotola S, Aruny J, Ross J, Vesely T, Patel N, Gray R, Durham J: Multicenter phase I results of the Bard PTFE stent graft trial for hemodialysis venous anastomotic graft stenoses. JVIR 14:S25, 2003 [Abstract] 9. Vogel PM, Parise C: SMART stent for salvage of hemodialysis access grafts. J Vasc Interv Radiol 15: , Vogel PM, Parise C: Comparison of SMART stent placement for arteriovenous graft salvage versus successful graft PTA. J Vasc Interv Radiol 16: , Patel RI, Peck SH, Cooper SG, Epstein DM, Sofocleous CT, Schur I, Falk A: Patency of Wallstents placed across the venous anastomosis of hemodialysis grafts after percutaneous recanalization. Radiology 209: , Hoffer EK, Sultan S, Herskowitz MM, Daniels ID, Sclafani SJ: Prospective, randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. J Vasc Interv Radiol 8: , Rajan DK, Clark TW: Patency of Wallstents placed at the venous anastomosis of dialysis grafts for salvage of angioplasty-induced rupture. Cardiovasc Interv Radiol 26: , Welber A, Schur I, Sofocleous CT, Cooper SG, Patel RI, Peck SH: Endovascular stent placement for angioplasty-induced venous rupture related to the treatment of hemodialysis grafts. J Vasc Interv Radiol 10: , Vesely TM: Endovascular intervention for the failing vascular access. Adv Renal Replace Therapy 9:99 108, 2002
Flow in hemodialysis grafts after angioplasty: Do radiologic criteria predict success?
Kidney International, Vol. 59 (2001), pp. 1974 1978 Flow in hemodialysis grafts after angioplasty: Do radiologic criteria predict success? SHUBHADA N. AHYA, DAVID W. WINDUS, and THOMAS M. VESELY Renal
More informationStent-grafts versus angioplasty and/or bare metal stents for failing arteriovenous grafts: a cross-over longitudinal study
ORIGINAL ARTICLE JN EPHROL 26( DOI: 10.5301/jn.5000161 Stent-grafts versus angioplasty and/or bare metal stents for failing arteriovenous grafts: a cross-over longitudinal study Dimitris Karnabatidis,
More informationStrategies to Reduce Catheter Use in 2014
Strategies to Reduce Catheter Use in 2014 Timothy A. Pflederer, MD Chair, Network 10 MRB (I have no commercial affiliations or conflicts of interest to report) Fibrin Sheathing Central Venous Stenosis
More informationTunneled Hemodialysis Catheters: Placement and complications
Tunneled Hemodialysis Catheters: Placement and complications Arif Asif, M.D. Director, Interventional Nephrology Associate Professor of Medicine University of Miami, FL Tunneled Hemodialysis Catheters:
More informationDialysis Vascular Access Coverage, Coding and Reimbursement Overview Physician / Hospital / ASC
Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Physician / Hospital / ASC 2015 Edition All Reimbursement Amounts are Listed at National Rates and Do Not Include the 2% Sequestration
More informationEndovascular Repair of an Axillary Artery Aneurysm: A Novel Approach
Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach Bao- Thuy D. Hoang, MD 1, Jonathan- Hien Vu, MD 2, Jerry Matteo, MD 3 1 Department of Surgery, University of Florida College of Medicine,
More informationCatheter Reduction Program: Creating the Ideal Vascular Access Culture. Presented by: Diane Peck, RN, CNN
Catheter Reduction Program: Creating the Ideal Vascular Access Culture Presented by: Diane Peck, RN, CNN Fistula First Initiative The superiority of an AVF over an AVG is an accepted fact. For this reason
More informationWhy do we need Dedicated Subspecialists and Interventionalists?
Optimal Hemodialysis Access Management and The Role of the Interventionalist Vascular Access Education Day May 2, 2009 Interior Health Authority Peter C. Gregory, MD Medical Director Vascular Access Center
More informationResection, Reduction, and Revision of Aneurysmal AV Fistulas
Resection, Reduction, and Revision of Aneurysmal AV Fistulas Patrick R. Cook DO, FACS Timothy G. Canty Jr. MD Robert J. Hye MD, FACS Kaiser Permanente San Diego, CA Aneurysmal AVF Over last decade K-DOQI
More informationThe treatment of peripheral vascular disease has
Covered s in Peripheral Vascular Aneurysms and Emergencies Reviewing current covered stent selection and use through case study and discussion. By Alberto Posabella, MD; Raffaele Rosso, MD, FACS, FRCS;
More informationHemodialysis, and therefore patent hemodialysis access, is of great
Diagn Interv Radiol DOI 10.5152/dir.2014.14348 Turkish Society of Radiology 2014 INTERVENTIONAL RADIOLOGY ORIGINAL ARTICLE Technical success of percutaneous transluminal balloon angioplasty and factors
More informationTalent Thoracic Stent Graft with THE Xcelerant Delivery System. Expanding the Indications for TEVAR
Talent Thoracic with THE Xcelerant Delivery System Expanding the Indications for TEVAR Talent Thoracic Precise placement 1 Broad patient applicability 1 Excellent clinical outcomes 1, a + Xcelerant Delivery
More informationPATIENT INFORMATION BOOKLET
PATIENT INFORMATION BOOKLET Wingspan Stent System with Gateway PTA Balloon Catheter TABLE OF CONTENTS Definitions... 2 What is the Purpose of This Booklet?... 3 What is an Intracranial Lesion?... 3 Who
More informationComplications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005
Complications of Femoral Catheterization Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005 Case Presentation xx yr old female presents with fever, chills, and painful swelling of R groin
More informationStenosis Surveillance 2009
5 Diamond Patient Safety Program Stenosis Surveillance 2009 *This presentation was collaboratively developed by the Mid-Atlantic Renal Coalition (MARC) and the ESRD Network of New England for the 5-Diamond
More informationGuidelines for the Management of Patients Following Endoluminal Vein Dilation Procedures for the Treatment of Multiple Sclerosis
Guidelines for the Management of Patients Following Endoluminal Vein Dilation Procedures for the Treatment of Multiple Sclerosis Report Submitted to the Minister of Health and Long-Term Care By the Ontario
More informationAntiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty
Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service April 26, 2016 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Bard
More informationPopliteal artery: to stent or not to stent?
Popliteal artery: to stent or not to stent? Karl-Ludwig Schulte Vascular Center Berlin Ev. Hospital Königin Elisabeth St. Gertrauden Hospital University Hospital Charité, CC11 Humboldt-University Berlin
More informationARROW-TREROTOLA PTD. Fast and easy removal of thrombi
ARROW-TREROTOLA PTD Fast and easy removal of thrombi ORDERING INFORMATION ARROW-TREROTOLA PTD 5 FR. Ref. Catheter length fragmentation basket sheath included rotator drive unit qty PT-03000-R 3000 rpm
More informationInstructions For Use
Instructions For Use B05667 Rev.4/05-14 INFORMATION FOR USE Caution: Federal law (U.S.) restricts the use of this device to sale by or on the order of a physician. Device Description The Fluency Plus
More informationWallFlex Biliary RX Stent. Fully, Partially and Uncovered Self-Expanding Metal Stents
WallFlex Biliary RX Stent Fully, Partially and Uncovered Self-Expanding Metal Stents WallFlex Biliary RX Stent Fully, Partially and Uncovered Self-Expanding Metal Stents The WallFlex Biliary RX Stent is
More informationMechanical Properties of Nitinol Stents and Stent-grafts. Comparison of 6 mm Diameter Devices
Mechanical Properties of Nitinol Stents and Stent-grafts Comparison of 6 mm Diameter Devices P E R F O R M A N C E b y d e s i g n Purpose The association of target vessel restenosis with stent fractures
More informationMajestic Trial 12 Month Results
Majestic Trial 12 Month Results S.Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA ACADEMIC HOSPITALS Flensburg of Kiel University Ev.-Luth. Diakonissenanstalt zu Flensburg Knuthstraße 1, 24939 FLENSBURG Dept.
More informationEFSUMB EUROPEAN FEDERATION OF SOCIETIES FOR ULTRASOUND IN MEDICINE AND BIOLOGY Building a European Ultrasound Community
MINIMUM TRAINING REQUIREMENTS FOR THE PRACTICE OF MEDICAL ULTRASOUND IN EUROPE Appendix 8: Vascular Ultrasound Level 1 Training and Practice Practical training should involve at least two half day ultrasound
More informationSTONY BROOK UNIVERSITY HOSPITAL VASCULAR CENTER CREDENTIALING POLICY
STONY BROOK UNIVERSITY HOSPITAL VASCULAR CENTER CREDENTIALING POLICY Per Medical Board decision March 18, 2008: These credentialing standards do NOT apply to peripheral angiography performed in the context
More informationUltrasound in Vascular Surgery. Torbjørn Dahl
Ultrasound in Vascular Surgery Torbjørn Dahl 1 The field of vascular surgery Veins dilatation and obstruction (varicose veins and valve dysfunction) Arteries dilatation and narrowing (aneurysms and atherosclerosis)
More informationCilostazol versus Clopidogrel after Coronary Stenting
Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background
More informationImaging of Thoracic Endovascular Stent-Grafts
Imaging of Thoracic Endovascular Stent-Grafts Tariq Hameed, M.D. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana Disclosures: No relevant financial
More informationLocal Coverage Article: Endovascular Repair of Aortic Aneurysms (A53124)
Local Coverage Article: Endovascular Repair of Aortic Aneurysms (A53124) Contractor Information Contractor Name Novitas Solutions, Inc. Article Information General Information Article ID A53124 Original
More informationOHTAC Recommendation
OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the
More informationCentral Venous Lines, PICCs, Ports and Pumps
Central Venous Lines, PICCs, Ports and Pumps 2012 CODING AND REIMBURSEMENT GUIDE Placement of a non-tunneled or tunneled device requires that the site of entry, type of device, age of patient and tunneling
More informationOverview of Newer Stent Devices for Aneurysm Treatment
Overview of Newer Stent Devices for Aneurysm Treatment Randall C. Edgell, M.D. Associate Professor Vascular and Interventional Neurology Saint Louis University Disclosure Outcome adjudication for THERAPY,
More informationContraindications: Malign or benign strictures in the upper part of esophagus close to the cricopharyngeal muscle.
Manufactured by: ELLA CS, s.r.o. Milady Horákové 504 500 06 Hradec Králové 6 Czech Republic Phone: +420 49 527 91 11 Fax: +420 49 526 56 55 E-mail: volenec@ellacs.cz Instructions for Use FerX-ELLA Esophageal
More informationVenous Stenting: Expectations and Reservations A panel of experts discusses patient selection, follow-up, and ideal technologies for the future.
Venous Stenting: Expectations and Reservations A panel of experts discusses patient selection, follow-up, and ideal technologies for the future. Participants Seshadri Raju, MD, FACS The RANE Center for
More informationRADIOLOGY 2014 CPT Codes
RADIOLOGY 2014 CPT Codes Radiology 2014 CPT Codes CMS has issued 36 new procedure codes (one is a radiation therapy code) for CY 2014 that directly pertain to radiology with 26 of those codes the result
More informationVascular Technology (VT) Content Outline Anatomy & physiology 20% Cerebrovascular Cerebrovascular normal anatomy Evaluate the cerebrovascular vessels
Vascular Technology (VT) Content Outline Anatomy & physiology 20% normal anatomy Evaluate the cerebrovascular vessels hemodynamics Evaluate the cerebrovascular vessels for normal perfusion normal anatomy
More informationUpper Extremity Vein Mapping for Placement of a Dialysis Access
VASCULAR TECHNOLOGY PROFESSIONAL PERFORMANCE GUIDELINES Upper Extremity Vein Mapping for Placement of a Dialysis Access This Guideline was prepared by the Professional Guidelines Subcommittee of the Society
More informationUnderstanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options. A Guide for Patients
Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options A Guide for Patients Coronary Artery Disease If you or a member of your family has been diagnosed with coronary artery
More informationCURRICULUM VITAE Catherine Mark Burdge, APRN
CURRICULUM VITAE Catherine Mark Burdge, APRN Education: 2002 Yale University, Post Masters Certificate Acute Care Nurse Practitioner Specialty 1983-1986 Yale University, Master of Science in Nursing Degree
More informationCredentials for Peripheral Angioplasty: Comments on Society of Cardiac Angiography and Intervention Revisions
Credentials for Peripheral Angioplasty: Comments on Society of Cardiac Angiography and Intervention Revisions David Sacks, MD, Gary J. Becker, MD, and Terence A.S. Matalon, MD J Vasc Interv Radiol 2003;
More informationFundación Favaloro. Fundación Favaloro
Superficial Femoral Artery: Which h Factors Influence Patency? Oscar A. Mendiz.MD.FACC.FSCAI Chairman hi of Interventional Cardiology dil March 2010 Name: Oscar A. Mendiz Disclosure I have the following
More informationREPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES
REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES Effective January 1, 2015, there was a change in CPT that affects reporting specific endovascular services provided in the
More informationRenal artery stenting: are there any indications left?
there any indications left? Luís Mendes Pedro, MD. PhD, FEBVS Lisbon Academic Medical Centre (University of Lisbon and Hospital Santa Maria) Instituto Cardiovascular de Lisboa Disclosures Speaker name:
More informationRenovascular Disease. Renal Artery and Arteriosclerosis
Other names: Renal Artery Stenosis (RAS) Renal Vascular Hypertension (RVH) Renal Artery Aneurysm (RAA) How does the normal kidney work? The blood passes through the kidneys to remove the body s waste.
More informationDuration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
More informationPediatric Hemodialysis Access
Pediatric Hemodialysis Access Vincent L. Rowe, M.D., FACS Professor of Surgery Division of Vascular Surgery Keck School of Medicine at University of Southern California NO FINANCIAL DISCLOSURES Outline
More informationCORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD
CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland CORONARY ARTERY BYPASS GRAFTS First performed
More informationUnderstanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page)
Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page) The Kidney and the Renal Arteries... 1 Renal Artery Disease... 2 Diagnosis of Renal.Artery Disease...
More informationComponents of CVC Care Bundle. selection
Components of CVC Care Bundle Catheter site selection Site of insertion influences the subsequent risk for CR-BSI and phlebitis The influence of site is related in part to the risk for thrombophlebitis
More informationConfirmed CCHD What next?
Confirmed CCHD What next? Herbert J. Stern MD, FACC, FSCAI Children s Cardiology Associates and Dell Children s Hospital Catheter Based Therapy: Spectrum of Procedures Tear PFO to enhance mixing (D-TGA)
More informationRELAY Plus Thoracic Stent-Graft System with Transport Delivery System
RELAY Plus Thoracic Stent-Graft System with Transport Delivery System TABLE OF CONTENTS Section Page DEVICE DESCRIPTION 8 RADIOPAQUE MARKER BANDS 8 RELAY PLUS TRANSPORT DELIVERY SYSTEM 8 INDICATIONS FOR
More informationJames J. Wynn, M.D. Medical College of Georgia
James J. Wynn, M.D. Medical College of Georgia Early patency Long durability (decades?) Resistance to infection Aesthetically acceptable Early referral to nephrologist Early evaluation to vascular surgeon
More informationClinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up
Hellenic J Cardiol 45: 379-383, 2004 Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up PETROS S. DARDAS, DIMITRIS
More informationResults of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament
From the Eastern Vascular Society Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament Keith D. Calligaro, MD, a Praveen Balraj, MD, a Neil Moudgill, MD, b Atul Rao,
More informationDialysis Access Procedures
2 Dialysis Access Procedures Khalid O. Khwaja Hemodialysis Introduction Surgical Procedures a) Radiocephalic Fistula b) Brachiocephalic Fistula c) Basilic Vein Transposition d) Forearm Loop Arteriovenous
More informationCoding Interventional Radiology Services
Coding Interventional Radiology Services Audio Seminar/Webinar March 20, 2008 Practical Tools for Seminar Learning Copyright 2008 American Health Information Management Association. All rights reserved.
More informationHemodialysis catheter infection
Hemodialysis catheter infection Scary facts In 2006, 82% of patients in the United States initiated dialysis via a catheter The overall likelihood of Tunneled cuffed catheters use was 35% greater in 2005
More informationTherapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
More informationVFI Technology to Change the Way You Work
Technology to Change the Way You Work Vascular Ultrasound Made Easier Vector Flow Imaging VFI VFI is a ground-breaking technology that can revolutionize the workflow for many Doppler ultrasound applications.
More informationNon-surgical treatment of severe varicose veins
Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in
More informationPurpose Members of the Department of Cardiology will provide cardiology services to patients of McLaren Greater Lansing.
Purpose Members of the Department of Cardiology will provide cardiology services to patients of McLaren Greater Lansing. Qualifications To be eligible for core privileges in the Department of Cardiology,
More informationIliac Artery Disease: A Case-Based Approach To Stent Selection
Society for Vascular Medicine Iliac Artery Disease: A Case-Based Approach To Stent Selection Annotated Cited Reference Material (2002). "MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin
More informationDept. of Medical Imaging University of Ottawa
ED Visits Related to Bariatric Surgery: Review of Normal Post-Surgical Anatomy as Well as Complications Dept. of Medical Imaging University of Ottawa Disclosures Background Roux-en-Y Gastric Bypass Surgery
More informationPercutaneous Transluminal Angioplasty (PTA) and Stenting For PVS Patients
Percutaneous Transluminal Angioplasty (PTA) and Stenting For PVS Patients There are two types of blood vessels in the body arteries and veins. Arteries carry blood rich in oxygen from the heart to all
More information2015 European Coronary Stent New Product Innovation Award
2015 European Coronary Stent New Product Innovation Award 2015 Contents Background and Company Performance... 3 Industry Challenges... 3 New Product Attributes and Customer Impact... 3 Conclusion... 4
More informationDeployment of a Self-expanding Stent in an Artery
Deployment of a Self-expanding Stent in an Artery Santosh Prabhu*, Chris Feezor*, Andy Denison*, Nuno Rebelo** and Mouhsine Serrar** * Guidant Corporation 3200 Lakeside Drive Santa Clara, CA 95054 and
More informationUltrasound - Vascular
Scan for mobile link. Ultrasound - Vascular Vascular ultrasound uses sound waves to evaluate the body s circulatory system and help identify blockages and detect blood clots. A Doppler ultrasound study
More informationAre venous catheters safe in terms of blood tream infection? What should I know?
Are venous catheters safe in terms of blood tream infection? What should I know? DIAGNOSIS, PREVENTION AND TREATMENT OF HAEMODIALYSIS CATHETER-RELATED BLOOD STREAM INFECTIONS (CRBSI): A POSITION STATEMENT
More informationPRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators
Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf
More informationHealthPACT Health Policy Advisory Committee on Technology Australia and New Zealand Technology Brief
HealthPACT Health Policy Advisory Committee on Technology Australia and New Zealand Technology Brief Percutaneous venoplasty for the treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple
More informationIAC 1/12/11 Nursing Board[655] Ch 6, p.1 CHAPTER 6 NURSING PRACTICE FOR REGISTERED NURSES/LICENSED PRACTICAL NURSES
IAC 1/12/11 Nursing Board[655] Ch 6, p.1 CHAPTER 6 NURSING PRACTICE FOR REGISTERED NURSES/LICENSED PRACTICAL NURSES 655 6.1(152) Definitions. Accountability means being obligated to answer for one s acts,
More informationIN.PACT ADMIRAL DRUG-COATED BALLOON NEW TECHNOLOGY ADD-ON PAYMENT (NTAP)
IN.PACT ADMIRAL DRUG-COATED BALLOON NEW TECHNOLOGY ADD-ON PAYMENT (NTAP) New Technology Add-on (NTAP) for DCB OVERVIEW Effective October 1, 2015, hospital inpatient cases using a drug-coated balloon (DCB)
More informationHow to Get Paid for. Today s s Agenda:
How to Get Paid for Imaging Services Performed in Surgery John Marshall CRA, RCC, RT(R), FAHRA john-marshall@smh.com Disclaimer John Marshall, his wife Adrienne and their dog Shakespeare, specifically
More informationReporting Transcatheter Aortic Valve Replacement (TAVR) Procedures in 2013
Reporting Transcatheter Aortic Valve Replacement (TAVR) Procedures in 2013 There are nine new CPT codes effective January 1, 2013, for reporting TAVR procedures. Five of these codes are Category I codes
More information1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia
PUBLICATIONS, ABSTRACTS AND PRESENTATIONS : 1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia 2. Endovascular management of the suprarenal IVC agenesis 3. The
More informationSurgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart
Surgical Options for Venous Disease Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Chronic Venous Disease Approximately 23% of adults in the US have varicose veins Estimated 22 million women
More informationAORTOENTERIC FISTULA. Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005
AORTOENTERIC FISTULA Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005 AORTOENTERIC FISTULA diagnosis and management Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005 AORTOENTERIC FISTULA Aortoenteric
More informationPulmonary Embolic Disease: Caval Filtration and Other Stuff. Tony P. Smith, M.D. October 2, 2009
Pulmonary Embolic Disease: Caval Filtration and Other Stuff Tony P. Smith, M.D. October 2, 2009 Controversies in Treatment of Acute Pulmonary Embolic Disease Scope of the problem Transcatheter therapy
More informationStentViz Enhanced Stent Visualization
GE Healthcare StentViz Enhanced Stent Visualization Dr. Morice, Dr. Lefèvre, Dr. Hovasse, Dr. Chevalier, Dr. Louvard Institut Cardiovasculaire Paris Sud, Massy, France Assessing the deployment of stents
More informationIntracoronary Stenting and. Robert A. Byrne, Julinda Mehilli, Salvatore Cassese, Franz-Josef Neumann, Susanne Pinieck, Tomohisa Tada,
Prospective, Randomized Trial of Paclitaxel-Eluting Balloon versus Paclitaxel-Eluting Stent versus Balloon Angioplasty for Treatment of Coronary Restenosis in Limus- Eluting Stents Intracoronary Stenting
More informationRenal Vascular Access Having a Fistula For Haemodialysis
Renal Vascular Access Having a Fistula For Haemodialysis Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationSummary Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in People with Multiple Sclerosis (MS)
ETMIS 2012; Vol. 8: N o 7 Summary Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in People with Multiple Sclerosis (MS) March 2012 A production of the Institut national d
More information100000002022.2. Instructions for Use. Cordis S.M.A.R.T. CONTROL Vascular Stent System
100000002022.2 Instructions for Use Cordis S.M.A.R.T. CONTROL Vascular Stent System Symbols Catalog Number LOT NonPyrogenic Lot Number Store in cool, dark, dry place Use By Date Sterilized with ethylene
More informationPatient Information Booklet. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms
Patient Information Booklet Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms TABLE OF CONTENTS Introduction 1 Glossary 2 Abdominal Aorta 4 Abdominal Aortic Aneurysm 5 Causes 6 Symptoms
More informationFirst Experience With Drug-Eluting Balloons in Infrapopliteal Arteries
Journal of the American College of Cardiology Vol. 58, No. 11, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.05.034
More informationSave the Vein: What Nurses Need to Know. Objectives. Importance of Vein Preservation. Why Focus on Vein Preservation? Chronic Kidney Disease
Description: This program focuses on the importance of vein preservation in chronic kidney disease (CKD) patients. At the heart of this project is a silicone wristband that reads SAVE VEINS NO IV/LAB DRAWS.
More informationA Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair
A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair Table of Contents The AFX Endovascular AAA System............................................ 1 What is an Abdominal Aortic Aneurysm
More informationCoronary Stents. What is a Coronary Artery stent?
What is a Coronary Artery stent? Coronary Stents A coronary stent is stainless tube with slots. It is mounted on a balloon catheter in a "crimped" or collapsed state. When the balloon of is inflated, the
More informationEndoscopic therapy for obesity and complications of bariatric surgery
Endoscopic therapy for obesity and complications of bariatric surgery Jacques Devière, MD, PhD Erasme University Hospital Brussels Belgium jacques.deviere@erasme.ulb.ac.be Obesity Affects 300 millions
More informationSummary. Signature: Pol J Radiol, 2013; 78(3): 74-79 DOI: 10.12659/PJR.889245
Signature: Pol J Radiol, 2013; 78(3): 74-79 DOI: 10.12659/PJR.889245 CASE REPORT Received: 2013.04.02 Accepted: 2013.07.16 Mechanical thrombectomy using Rotarex system and stent-in-stent placement for
More informationINSTEAD at 5-year follow-up shifts the expectations for endovascular treatment
INSTEAD at 5-year follow-up shifts the expectations for endovascular treatment Christoph A. Nienaber, MD, FACC University Heart Center Rostock Department of Medicine I - Cardiology christoph.nienaber@med.uni-rostock.de
More informationClinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b
Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy Statement: Percutaneous
More informationSUTTER MEDICAL CENTER, SACRAMENTO Department of Cardiovascular Disease Cardiology - Delineation of Privileges
INITIAL: [ ] RENEWED: [ ] DATE: ADDITIONAL: [ ] Privileges are granted for Sutter General Hospital, Sutter Memorial Hospital, Sutter Center for Psychiatry, Sutter Oaks Midtown and the Capitol Pavilion
More informationEndovascular Revascularization of the Lower Extremity (APCs 0083, 0229 and 0319)
Marilyn B. Tavenner Acting Administrator Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS 1589 P, Mail Stop C4 26 05, 7500 Security Boulevard, Baltimore,
More informationA Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III
A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardial InfarctiON in Real Life APPOSITION III Gilles Montalescot, MD, PhD Pitié-Salpêtrière Hospital, Paris, France
More informationDrug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam
Drug-Eluting Balloons Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Potential conflicts of interest Speaker s name: Klaus Bonaventura
More information